Just – Evotec Biologics revenue declined 38% to EUR 36.8 million , primarily due to the absence of the prior- year Sandoz license payment and an "expected decline in DOW revenues," according to Hinshelwood. She added that the decline was partially offset by about 50% year-on-year growth in non-DOW, non-Sandoz revenues . On a constant-currency basis, segment revenue was EUR 40.4 million . Just's adjusted EBITDA decreased to negative EUR 12.1 million (or negative EUR 13.4 million at constant exchange rates), ...